The transforming growth factor (TGF-) proteins are a family of multifunctional cytokines that regulate many aspects of cellular function and consequently have diverse eVects on a variety of cell types and tissues. Although five highly homologous types of TGF-have been characterised, only the first three isoforms are found in mammals. 1 2 TGF-elicit their eVects by binding to cell surface receptors. Three major types of TGFbinding proteins are known to be widely distributed in most TGF-responsive cells. They are referred to as TGF-type I (T RI), type II (T RII), and type III (or -glycan) (T RIII) receptors. T RI and T RII are glycoproteins of 53 and 75 kDa, respectively, whereas T RIII is a proteoglycan of 280-330 kDa. [3] [4] [5] T RI and T RII possess an extracellular region, a single transmembrane portion, and a serine/threonine kinase domain in the cytoplasmic region. T RII can bind free ligand whereas T RI can only recognise ligand that is already bound with T RII, and formation of a ligand induced heterotetramer involving both T RI and T RII is required for signalling. In contrast, T RIII lacks a cytoplasmic protein kinase domain and appears to function mainly in the concentration and presentation of TGF to T RI and T RII. 6 Signalling by these receptors is mediated by the recently identified Smad protein family. 7 TGF-1 appears to be an important regulator in both normal and pathological conditions in the liver. 8 TGF-1 is synthesised in nonparenchymal cells such as hepatic stellate cells (HSC) 9 and inhibits hepatocellular DNA synthesis both in culture and in vivo. Picomolar concentrations of TGF-1 suppress hepatocyte DNA synthesis in culture. 10 Moreover, injection of TGF-1 into partially hepatectomised rats significantly delays the onset of DNA synthesis. 11 In addition, TGF-1 increases the synthesis and deposition of extracellular matrix (ECM) proteins such as fibronectin by HSC and is closely associated with the progression of hepatic fibrosis. 8 12 The level of DNA synthesis in parenchymal hepatocytes and mRNA expression of fibronectin and TGF-1 in non-parenchymal cells are maximal approximately 48 hours after acute CCl 4 intoxication. 9 13-15 However, these results raise the question of why maximal levels of DNA synthesis are seen when the level of TGF-1, which inhibits hepatocyte proliferation, is already elevated and ECM is produced by non-parenchymal cells such as HSC. To answer this question, in a previous report we analysed expression of TGF-and its receptor mRNAs in both hepatocytes and nonparenchymal cells after CCl 4 administration.
The results showed that there is downregulation of TGF-receptor mRNAs in hepatocytes but that levels remain high in non-parenchymal cells after CCl 4 administration. However, it is currently unclear if the cell type specific changes in mRNA expression reflect the abilities of TGF-receptors to bind ligand and TGF-signal. Therefore, in this study we focused our eVorts on alternations in the sensitivity to TGF-1 and binding properties for ligand in both hepatocytes and HSC after CCl 4 administration.
Materials and methods

ANIMALS
Eight to nine week old, 200-300 g male Wistar rats were obtained from Oriental Bio Service Co. (Kyoto, Japan) and were used in all experiments. All procedures were carried out in accordance with the Declaration of Helsinki and Guiding Principles on the Care and Use of Animals. For studies of liver regeneration after toxic injury, rats were given a single intragastric dose of 0.5 ml of a 1:1 (v/v) mixture of CCl 4 in olive oil per 100 g body weight. These animals were sacrificed at 0, 24, 48, 72, and 96 hours after administration of the agent. Blood was collected into heparinised syringes at sacrifice, and plasma samples were stored at −80°C until use.
MEASUREMENT OF TGF-1 BY ELISA
To determine the concentration of TGF-1 in rat plasma after CCl 4 administration, we used an enzyme-linked immunoassay kit for human TGF-1 (R&D Systems Inc., Minneapolis, Minnesota, USA) that cross reacts with the rat protein. Values are expressed in ng/ml with a lower limit of detection of 0.005 ng/ml.
CELL SEPARATION PROCEDURE
Hepatocytes and HSC were isolated from normal rat liver or rat liver injured at 48 and 72 hours after CCl 4 administration. HSC were obtained using collagenase and pronase-E digestion according to the modified method of Knook and colleagues. 16 The liver was perfused in a non-circulating system for two minutes at 37°C (40 ml/min). The perfusion solution was calcium free Hanks buVer (137 mM NaCl, 5.4 mM KCl, 0.5 mM NaH 2 PO 4 , 0.42 mM Na 2 HPO 4 , 5 mM glucose, 25 mM NaHCO 3 , 10 mM HEPES, and 0.5 mM EGTA at pH 7.2-7.3). The livers were then circulated with the perfusion solution for five minutes. A solution (200 ml) consisting of 0.1% collagenase (Wako, Osaka, Japan) in 10 mM HEPES, pH 7.5, with 5 mM calcium without EGTA was recirculated for 5-10 minutes. The liver was cut into pieces and incubated in 100 ml of Gey's balanced salt solution with 0.1% pronase-E (Sigma, St Louis, Missouri, USA) on a magnetic stirrer at 37°C for 30 minutes. At the end of the incubation period, the suspension was filtered through Nylon gauze and the filtrate was centrifuged at 450 g for seven minutes. The collected cells were centrifuged on a two layer density cushion of Nycodenz (Nycomed, Oslo, Norway) (Gey's balanced salt solution/8% Nycodenz) at 1400 g for 17 minutes. The HSC fraction was collected from the upper layer. The purity of the HSC was greater than 90%, as assessed by typical morphological features and the immunological staining of desmin. Hepatocytes were prepared by perfusion of the liver in situ with collagenase and purified by centrifugal elutriation as previously described. 15 LIVER CELL CULTURE Purified cells were kept in culture at 37°C in a 5% CO 2 atmosphere and 100% humidity. Hepatocytes were cultured in Williams' medium E supplemented with 5% fetal calf serum (FCS), 10 nM dexamethazone, 100 units/ml penicillin G, and 0.1 mg/ml streptomycin. HSC were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% FCS, 100 units/ml penicillin G, and 0.1 mg/ml streptomycin.
ASSAY OF DNA SYNTHESIS
The isolated hepatocytes were suspended in culture medium at 1×10 5 cells/ml and seeded into 24 well dishes (0.5 ml/dish). After two hours the medium was changed to serum free Williams' medium E. Various concentrations of porcine TGF-1 (R&D Systems Inc.) with or without 10 ng/ml of recombinant human hepatocyte growth factor (HGF) (R&D Systems Inc.) were added to the medium 12 hours after seeding. After further incubation for 24 hours, 2 µCi/well of [methyl- H]thymidine (25 Ci/ mmol; Amersham, Buckinghamshire, UK) were added to the medium and culture was continued for three hours. At the end of the pulsing period, the medium was carefully aspirated, icecold 5% trichloroacetic acid was added, and dishes were kept on ice for 15 minutes. After two additional washes with 5% trichloroacetic acid, cells were solubilised by adding 500 µl of 0.5 N NaOH. The solubilised cell solution (250 µl) was then neutralised with 0.5 N HCl (250 µl) and radioactivity (cpm) measured in a liquid scintillation counter.
MEASUREMENT OF FIBRONECTIN PRODUCTION
Fibronectin production was measured as described, with minor modifications. 17 The isolated HSC were suspended in culture medium at 2×10 5 cells/ml and seeded into 12 well dishes. After two hours the medium was changed to fresh culture medium containing 0.2% FCS. After five hours the cells were incubated with or without various concentrations of TGF-1 for 20 hours and labelled with 50 µCi of a [ ]cysteine mixture (Pro-mix cell labelling mix: Amersham) in 1 ml of methionine and cysteine free DMEM (ICN Pharmaceuticals, Costa Mesa, California, USA) for the final four hours. Labelled culture media (1 ml) were collected and labelled fibronectin was purified by absorption to 100 µl of gelatin-sepharose (Pharmacia, Uppsala, Sweden) in the presence of 0.5% Triton X-100. The beads were washed once in Tris buVered saline (50 mM Tris HCl, pH 7.4, 150 mM NaCl), once in 50 mM Tris HCl (pH 7.4), 0.5 M NaCl, and once in Tris buVered saline. Fibronectin was eluted by boiling in sodium dodecyl sulphate (SDS) sample buVer in the presence of 10 mM dithiothreitol. The samples were analysed by 7% SDS-polyacrylamide gel electrophoresis (PAGE) and autoradiography. Relative amounts of fibronectin were quantified by densitometric scanning.
BINDING AND COVALENT AFFINITY CROSS LINKING OF LIGAND
Carrier free TGF-1 was iodinated to a specific activity of 1×10 5 cpm/ng (25 µCi/ng) by the chloramine T method as previously described. 18 The isolated hepatocytes and HSC were suspended in culture medium at 3×10 6 cells/ml and seeded onto 10 cm dishes. After three hours, cell monolayers were incubated for one hour at 4°C with 200 pM 125 I labelled TGF-1 alone or with excess (5 nM) unlabelled TGF-1. Receptors were cross linked to bound ligand with disuccinimidyl suberate and solubilised in the presence of Triton X-100 as previously described. 19 Cell extracts were clarified by centrifugation and then subjected to 7% SDS-PAGE and autoradiography.
STATISTICAL ANALYSIS
Data are expressed as mean (SD). Experimental and control values were compared using the unpaired Student's t test and ANOVA; p<0.05 was considered significant.
Results
ELEVATION OF TGF-1 LEVEL IN RAT PLASMA AFTER CCL 4 ADMINISTRATION
Using northern blot hybridisation we observed approximately fivefold induction of TGF-1 mRNA in regenerating livers at 48 hours after CCl 4 administration. 9 15 To determine if protein levels also increased we measured TGF-1 protein by ELISA in rat plasma after CCl 4 administration. Figure 1 illustrates the results of plasma TGF-1 measurements after CCl 4 administration. Plasma levels of TGF-1 were increased as early as 24 hours and were maximal by 48 hours, reaching five times that in normal plasma and decreasing thereafter.
Plasma levels of TGF-1 were essentially unchanged in the rat treated only with olive oil at various times between 24 and 96 hours. Consistent with mRNA induction, TGF-1 protein was induced in the injured liver. These results suggest that elevated levels of TGF-1 have potential roles in liver regeneration and ECM production. Therefore, we studied the time dependent diVerential sensitivity of individual liver cell types to the growth inhibitory eVect of TGF-1 and its induction of ECM expression.
DIFFERENTIAL ANTIPROLIFERATIVE RESPONSE OF TGF-1 ON HEPATOCYTES AFTER CCL 4 ADMINISTRATION
First we examined if TGF-1 induced by liver injury aVected hepatocyte growth. The eVect of TGF-1 on cellular proliferation was studied by measuring [methyl-
3 H] thymidine incorporation into the DNA of hepatocytes. Figure 2 shows the eVects of TGF-1 on DNA synthesis of normal hepatocytes in the presence or absence of exogenous HGF. HGF induced a fivefold increase in DNA synthesis of hepatocytes. TGF-1 inhibited DNA synthesis of hepatocytes not only in the absence but also in the presence of exogenous HGF in a dose dependent manner in the range 1-10 4 pg/ml, consistent with previous reports. 20 This eVect was half maximal with approximately 10 pg/ml TGF-1.
It is not clear why maximal levels of DNA synthesis are observed at 48 hours in spite of the increased levels of TGF-1 which inhibit hepatocyte proliferation. To determine this we monitored the sensitivity of hepatocytes to the growth inhibitory eVect of TGF-1 after CCl 4 administration and compared DNA synthesis of normal liver in the presence of TGF-1 with that of injured liver. In the presence of 10 pg/ml TGF-1, HGF induced DNA synthesis in normal hepatocytes was reduced to approximately 50%. This inhibitory eVect of TGF-1 was decreased to approximately 20% Figure 1 in hepatocytes at 48 hours after CCl 4 administration and returned to normal levels at 72 hours ( fig 3) . These results indicated that hepatocytes at 48 hours after chemical insults showed a reduced response to growth inhibition by TGF-1.
STIMULATION OF FIBRONECTIN PRODUCTION BY TGF-1 IN HSC AFTER CCl 4 ADMINISTRATION
At the regenerating stage of the liver, hepatocytes seemed to be resistant to TGF-1 stimuli although the protein level of TGF-1 was already increased. However, this leads to the question of whether the elevated TGF-1 has other biological eVects on non-parenchymal cells. In addition, TGF-1 increased synthesis and deposition of ECM proteins in many mesenchymal cells. 1 2 Therefore, we next examined ECM production from non-parenchymal cells. We used HSC because of the central importance for ECM production and liver fibrosis. 21 Furthermore, we examined fibronectin production because fibronectins are major components in the liver and representative of the various matrix proteins induced by TGF-1. The sensitivity of HSC to TGF-1 at 48 hours after chemical insult needs to be studied because hepatocyte growth is resistant to TGF-1 at this time. Therefore, we compared fibronectin production of normal HSC in the presence of TGF-1 with that of HSC after CCl 4 administration (fig 5) . The level of fibronectin was already elevated in activated HSC after CCl 4 administration. However, similar to normal HSC, 100 pg/ml TGF-1 stimulated fibronectin production in HSC at 48 hours when hepatocytes, after chemical insult, showed a reduced response to growth inhibition by TGF-1. This indicated that fibronectin production of HSC after CCl 4 I TGF-1-T RII complexes were observed in normal hepatocytes as well as HSC. However, 125 I TGF-1-T RIII complexes were scarcely detected. At 48 hours after CCl 4 administration, T RI and T RII in hepatocytes interacted very weakly with ligand. Then, the ability of two TGF-receptors to bind ligand recovered, reaching normal levels at 72 hours. Our results using a receptor cross linking assay suggested that expression of T RI and T RII was depressed specifically in hepatocytes at 48 hours after CCl 4 administration. Unlike in hepatocytes, the ability of T RI and T RII to bind ligand did not decrease in HSC during treatment.
Discussion
In this present study we addressed the important question of the role of TGF-in regulating cell proliferation and ECM synthesis following rat liver injury. We have reported previously that the levels of T RI and T RII mRNA expression in rat hepatocytes decreased from 12 to 48 hours and returned to normal by 72 hours after CCl 4 administration while T RI and T RII mRNA were expressed constantly in non-parenchymal cells. 15 TGF-is known to be the most potent growth inhibitor for a wide variety of cell types, including hepatocytes. 1 10 Our results showed that the inhibitory eVect of TGF-1 decreased in hepatocytes at 48 hours after CCl 4 administration and returned to normal level at 72 hours. Consistent with downregulation of the mitoinhibitory eVect, DNA synthesis in hepatocytes reached a peak at 48 hours after CCl 4 administration. This result raises the possibility that downregulation of the mitoinhibitory eVect of TGF-1 enhances the eVect of mitogenic factor induced by chemical insult. During the proliferative phase, there is an inverse correlation between expression of the TGF-receptor and DNA synthesis in hepatocytes. These observations suggest that by decreasing receptor expression, TGF-1 cannot transduce its antiproliferative signal via TGF-receptors on hepatocytes. Furthermore, return of receptor expression to a normal level in the later stages of regeneration may account for the return in hepatocyte sensitivity to TGF-and may be involved in limiting hepatocyte proliferation once the liver has regenerated.
Although the mechanism of reduction of TGF-receptor transcripts is currently unknown, several reports analysed the promoter region of T RII to pursue the transcriptional mechanism of this gene. Bae et al identified two positive regulatory elements and at least one negative regulatory element in the promoter region of T RII. 23 Furthermore, Kim et al reported that an absolute reduction of T RII mRNA followed by transformation of keratinocytes with E1A oncogene is the result of decreased expression of unidentified transcription factor complexes that interact with two positive regulatory elements. 24 Therefore, we speculate that downregulation of T RII in hepatocytes is caused by a decrease in these transcription factors.
Among the most striking eVects of TGFon cellular function in vitro is its promotion of extracellular formation. TGF-increases synthesis and deposition of extracellular components such as fibronectin and some forms of collagen. 1 8 In the liver, HSC is an important eVector of hepatic fibrosis. 12 21 Despite depression of TGF-receptor levels in hepatocytes, these levels remained constant in HSC in the liver injured by CCl 4 treatment. In addition, TGF-1 stimulated the production of fibronectin even by injured HSC. These results suggest that TGF-1 induces many components of the ECM by an autocrine mechanism 
